Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PHF6-somatic mutations and their role in pathophysiology of MDS and AML
    Meeting Abstract

    Przychodzen, B.; Gu, X. R.; You, D. W.; Hirsch, C. M.; Clemente, M. J.; Viny, A. D.; Levine, R. L.; Haferlach, T.; Maggendorfer, M.; Sekeres, M. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Tipifarnib as maintenance therapy in acute myeloid leukemia (AML) improves survival in a subgroup of patients with high risk disease. Results of the phase III intergroup trial E2902
    Meeting Abstract

    Luger, S.; Wang, V. X.; Paietta, E.; Ketterling, R. P.; Rybka, W.; Lazarus, H. M.; Litzow, M. R.; Rowe, J. M.; Larson, R. A.; Appelbaum, F. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Real-world ponatinib prescribing patterns and outcomes in US patients
    Meeting Abstract

    Mauro, M. J.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Blood (2015)

    Fulltext@MSK | Save
  • Lysine-specific histone demethylase, LSD1, (KDM1A) as a novel therapeutic target in myeloproliferative neoplasms
    Meeting Abstract

    Kleppe, M.; Shank, K.; Papalexi, E.; Riehnhoff, H.; Levine, R. L.
    Blood (2015)

    Fulltext@MSK | Save
  • BAP1 loss results in EZH2-dependent transformation in myelodysplastic syndromes
    Meeting Abstract

    LaFave, L. M.; Beguelin, W.; Koche, R.; Teater, M.; Papalexi, E.; Spitzer, B.; Knutson, S.; Campbell, J.; Keilhack, H.; Thomas, P. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Autologous transplant, and not ATO alone, remains the preferred therapy for relapsed APL: A report from the CIBMTR, EBMT and two specialized centers
    Meeting Abstract

    Ganzel, C.; Mathews, V.; Alimoghaddam, K.; Ghavamzadeh, A.; Kuk, D.; Devlin, S.; Wang, H. L.; Weisdorf, D.; Douer, D.; Rowe, J. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • In Philadelphia-chromosome-negative acute lymphoblastic leukemia, late relapses are not uncommon, occur mostly in patients at standard risk and have a relatively favorable outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993
    Meeting Abstract

    Ganzel, C.; Victoria, W. X.; Fielding, A. K.; Rowe, J. M.; Richards, S. M.; Buck, G.; Chopra, R.; Durrant, I. J.; Marks, D.; Franklin, I. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Divergent dynamics of epigenetic and genetic heterogeneity in relapsed acute myeloid leukemia
    Meeting Abstract

    Garrett-Bakelman, F. E.; Li, S.; Chung, S. S.; Hricik, T.; Rapaport, F.; Patel, J.; Dillon, R.; Vijay, P.; Brown, A. L.; Perl, A. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Hairy cell leukemia variant has similar survival to classical disease despite poorer responses to initial therapy: A 30-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Woo, K. M.; Devlin, S.; Park, J. H.; Abdel-Wahab, O.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Prmt5 negatively regulates erythropoiesis by multiple mechanisms, including controlling DNA methyltransferase 3A protein levels
    Meeting Abstract

    Hamard, P. J.; Luciani, L.; Liu, F.; Cheng, G. Y.; Hatlen, M. A.; Guryanova, O. A.; Zhao, X. Y.; Levine, R. L.; Nimer, S. D.
    Blood (2015)

    Fulltext@MSK | Save